What is the share price of Asarfi Hospital Ltd (ASARFI) today?
The share price of ASARFI as on 8th December 2025 is ₹195. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Asarfi Hospital Ltd (ASARFI) share?
The past returns of Asarfi Hospital Ltd (ASARFI) share are- Past 1 week: 5%
- Past 1 month: 39.51%
- Past 3 months: 43.07%
- Past 6 months: 41.66%
- Past 1 year: 97.69%
- Past 3 years: N/A%
- Past 5 years: 87.97%
What are the peers or stocks similar to Asarfi Hospital Ltd (ASARFI)?
The peers or stocks similar to Asarfi Hospital Ltd (ASARFI) include:What is the market cap of Asarfi Hospital Ltd (ASARFI) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Asarfi Hospital Ltd (ASARFI) is ₹392.56 Cr as of 8th December 2025.What is the 52 week high and low of Asarfi Hospital Ltd (ASARFI) share?
The 52-week high of Asarfi Hospital Ltd (ASARFI) is ₹221 and the 52-week low is ₹72.90.What is the PE and PB ratio of Asarfi Hospital Ltd (ASARFI) stock?
The P/E (price-to-earnings) ratio of Asarfi Hospital Ltd (ASARFI) is 37.10. The P/B (price-to-book) ratio is 4.85.Which sector does Asarfi Hospital Ltd (ASARFI) belong to?
Asarfi Hospital Ltd (ASARFI) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Asarfi Hospital Ltd (ASARFI) shares?
You can directly buy Asarfi Hospital Ltd (ASARFI) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Asarfi Hospital Ltd
ASARFI Share Price
ASARFI Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
ASARFI Performance & Key Metrics
ASARFI Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 28.91 | 4.85 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.87 | 5.82 | 0.59% |
ASARFI Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
ASARFI Company Profile
Asarfi Hospital Limited is an integrated healthcare service provider in India, operating a 250-bedded multi-specialty hospital. It offers comprehensive healthcare services, including prevention, treatment, and rehabilitation across various medical departments such as cardiology, surgery, and pediatrics.
ASARFI Sentiment Analysis
ASARFI Sentiment Analysis
ASARFI Stock Summary · November 2025
The hospital's financial results for the first half of FY26 reflect a robust growth trajectory, with a 50% year-on-year increase in revenue, driven by strategic expansions and enhanced service offerings, including a new Bone Marrow Transplant Unit. However, challenges persist, notably a 67% rise in trade receivables linked to a heavy reliance on government contracts, which complicates cash flow management. Community engagement initiatives, such as health camps and cancer screenings, bolster the hospital's reputation, while efforts to improve staff retention are critical amid a 20-30% attrition rate. Looking ahead, the company aims to optimize operational efficiency and increase patient volume, targeting a PAT margin improvement to 13-15% by FY27.
ASARFI Stock Growth Drivers
ASARFI Stock Growth Drivers
7Strong Financial Performance
Asarfi Hospital Limited reported a significant revenue increase of 50% year-on-year, reaching Rs. 80.6 crores
Expansion of Services and Facilities
The hospital is expanding its bed capacity to 500 by 2027, with plans to scale
ASARFI Stock Challenges
ASARFI Stock Challenges
3Regulatory Challenges Impacting Revenue Projections
The company faces significant regulatory challenges related to organ procurement, which have resulted in a
Decline in General Medicine Mix
There has been a noted decline in the general medicine mix, attributed to seasonal fluctuations.
ASARFI Forecast
ASARFI Forecasts
ASARFI
ASARFI
Income
Balance Sheet
Cash Flow
ASARFI Income Statement
ASARFI Income Statement
| Financial Year | FY 2024 | FY 2025 | TTM | |||
|---|---|---|---|---|---|---|
| Total Revenue | 86.07 | 128.09 | 155.24 | |||
| Raw Materials | 20.52 | 28.49 | 119.47 | |||
| Power & Fuel Cost | 1.78 | 2.68 | ||||
| Employee Cost | 13.48 | 17.83 | ||||
| Selling & Administrative Expenses | 24.23 | 38.71 | ||||
| Operating & Other expenses | 8.32 | 9.31 | ||||
| EBITDA | 17.74 | 31.07 | 35.77 | |||
| Depreciation/Amortization | 8.79 | 12.68 | 12.20 | |||
| PBIT | 8.95 | 18.39 | 23.57 | |||
| Interest & Other Items | 2.71 | 4.08 | 4.82 | |||
| PBT | 6.24 | 14.31 | 18.75 | |||
| Taxes & Other Items | 2.08 | 3.73 | 5.17 | |||
| Net Income | 4.16 | 10.58 | 13.58 | |||
| EPS | 2.11 | 5.38 | 6.90 | |||
| DPS | 0.00 | 0.00 | 0.00 | |||
| Payout ratio | 0.00 | 0.00 | 0.00 |
ASARFI Company Updates
ASARFI Stock Peers
ASARFI Past Performance & Peer Comparison
ASARFI Past Performance & Peer Comparison
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Asarfi Hospital Ltd | 37.10 | 4.85 | — |
| Max Healthcare Institute Ltd | 99.22 | 11.38 | 0.14% |
| Apollo Hospitals Enterprise Ltd | 71.49 | 9.31 | 0.18% |
| Fortis Healthcare Ltd | 86.64 | 7.32 | 0.11% |
ASARFI Stock Price Comparison
Compare ASARFI with any stock or ETFASARFI Holdings
ASARFI Shareholdings
ASARFI Promoter Holdings Trend
ASARFI Promoter Holdings Trend
ASARFI Institutional Holdings Trend
ASARFI Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
ASARFI Shareholding Pattern
ASARFI Shareholding Pattern
ASARFI Shareholding History
ASARFI Shareholding History
smallcases containing ASARFI stock
smallcases containing ASARFI stock
Looks like this stock is not in any smallcase yet.
ASARFI Events
ASARFI Events
ASARFI Dividend Trend
ASARFI has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
ASARFI Dividend Trend
ASARFI has not given any dividends in last 5 years
ASARFI Dividends
ASARFI Dividends
ASARFI Stock News & Opinions
ASARFI Stock News & Opinions
Net profit of Asarfi Hospital rose 47.37% to Rs 4.20 crore in the quarter ended September 2025 as against Rs 2.85 crore during the previous quarter ended September 2024. Sales rose 45.46% to Rs 44.89 crore in the quarter ended September 2025 as against Rs 30.86 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales44.8930.86 45 OPM %19.7621.91 - PBDT8.567.13 20 PBT5.653.94 43 NP4.202.85 47 Powered by Capital Market - Live
Asarfi Hospital announced that the 20th Annual General Meeting(AGM) of the company will be held on 12 September 2025.Powered by Capital Market - Live
Asarfi Hospital will hold a meeting of the Board of Directors of the Company on 20 August 2025.Powered by Capital Market - Live
Net profit of Asarfi Hospital rose 115.17% to Rs 3.12 crore in the quarter ended June 2025 as against Rs 1.45 crore during the previous quarter ended June 2024. Sales rose 55.67% to Rs 35.68 crore in the quarter ended June 2025 as against Rs 22.92 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales35.6822.92 56 OPM %19.5920.72 - PBDT7.194.64 55 PBT4.201.45 190 NP3.121.45 115 Powered by Capital Market - Live
Asarfi Hospital will hold a meeting of the Board of Directors of the Company on 7 August 2025.Powered by Capital Market - Live
Net profit of Asarfi Hospital reported to Rs 3.59 crore in the quarter ended March 2025 as against net loss of Rs 0.21 crore during the previous quarter ended March 2024. Sales rose 40.97% to Rs 33.89 crore in the quarter ended March 2025 as against Rs 24.04 crore during the previous quarter ended March 2024. For the full year,net profit rose 154.33% to Rs 10.58 crore in the year ended March 2025 as against Rs 4.16 crore during the previous year ended March 2024. Sales rose 42.86% to Rs 120.57 crore in the year ended March 2025 as against Rs 84.40 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales33.8924.04 41 120.5784.40 43 OPM %14.9616.43 -19.5319.02 - PBDT8.552.77 209 26.9915.03 80 PBT5.30-0.72 LP 14.316.24 129 NP3.59-0.21 LP 10.584.16 154 Powered by Capital Market - Live
Asarfi Hospital will hold a meeting of the Board of Directors of the Company on 8 May 2025.Powered by Capital Market - Live
Net profit of Asarfi Hospital reported to Rs 2.72 crore in the quarter ended December 2024 as against net loss of Rs 0.05 crore during the previous quarter ended December 2023. Sales rose 64.04% to Rs 32.89 crore in the quarter ended December 2024 as against Rs 20.05 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales32.8920.05 64 OPM %21.2219.95 - PBDT6.694.60 45 PBT3.651.35 170 NP2.72-0.05 LP Powered by Capital Market - Live
Asarfi Hospital will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live
Asarfi Hospital will hold a meeting of the Board of Directors of the Company on 30 October 2024.Powered by Capital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant